Related Experiment Videos
Inhibition of bacterial IF2 binding to fMet-tRNA((fMet)) by aminoglycosides
J M Evans1, B A Turner, S Bowen
1Global High Throughput Screening, Pharmacia Corp., Kalamazoo, MI 49007, USA.
Abstract:
Screening for inhibitors of bacterial protein synthesis Initiation Factor 2 (IF2) binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA((fMet))) identified a series of aminoglycosides, that included amikacin and kanamycin A1, as inhibitors of this interaction. Subsequent testing revealed that aminoglycosides displayed a wide range of inhibitory activity. However, the failure of these compounds to completely inhibit binding of IF2 to fMet-tRNA((fMet)), the known ability of aminoglycosides to bind RNA, and the ability of the aminoglycosides to displace PicoGreen bound to fMet-tRNA((fMet)) suggest these compounds act by binding fMet-tRNA((fMet)). This hypothesis is further supported by isothermal denaturation experiments that failed to show any interaction between the IF2 protein and the aminoglycosides.
Insights
Aminoglycosides like amikacin inhibit bacterial protein synthesis by binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA), not Initiation Factor 2 (IF2). This discovery offers new insights into antibiotic mechanisms.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Bacterial protein synthesis is a crucial target for antibiotics.
- Initiation Factor 2 (IF2) plays a vital role in initiating protein synthesis by binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA).
- Understanding the precise molecular interactions in this process can lead to the development of novel antibacterial agents.
Purpose of the Study:
- To identify inhibitors of the interaction between bacterial IF2 and fMet-tRNA.
- To elucidate the mechanism of action of identified inhibitors.
Main Methods:
- Screening of compounds for inhibition of IF2-fMet-tRNA binding.
- Assessing the range of inhibitory activity of identified compounds.
- Investigating the binding interactions using PicoGreen displacement assays.
- Conducting isothermal denaturation experiments to study protein-ligand interactions.
Main Results:
- A series of aminoglycosides, including amikacin and kanamycin A1, were identified as inhibitors of IF2-fMet-tRNA binding.
- Aminoglycosides exhibited varying degrees of inhibitory activity.
- Evidence suggests aminoglycosides primarily bind to fMet-tRNA rather than IF2.
- Isothermal denaturation experiments showed no direct interaction between IF2 protein and aminoglycosides.
Conclusions:
- Aminoglycosides inhibit bacterial protein synthesis initiation by targeting fMet-tRNA.
- This binding to fMet-tRNA, rather than IF2, represents a distinct mechanism of action.
- Findings provide a deeper understanding of aminoglycoside antibiotic function and potential for new drug development.